Snowball logo
logo
3001

Xiangxue Pharmaceutical

300147 SHE
¥7.45+¥0.06  (0.81%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2,970.62,187.12,299.31,858.71,595.41,521.2
COGS
2,229.21,653.71,5561,451.11,159.51,113.4
Gross Profit
741.4533.4743.3407.6435.9407.8
Operating Expenses & Income
Operating Income
(588.7)(464.1)(332.7)(784.5)(76.6)(150.2)
Total Operating Expenses
1,330.1997.51,076.11,192.11,6721,161.9
R&D Expenses
90.694.7989.7692.2970.9568.49
Selling General & Admin Expenses
263.8255.6240.3285.8155.3493.1
Earnings from Continuing Operations
Interest Expense
(213.2)(216.5)(242.7)(232.9)(284.1)(297.3)
Interest Income
8.2506983.9133731.2041932.7767770.7949910.692929
Income Tax Expense
22.92(7.215065)12.819.15-2.490694
Net Income
Net Income
(688.5)(530.1)(389)(858.6)(1,392.2)(1,415.9)
Supplemental
EBIT
(22.39)(175.3)49.67(233.9)--
EBITDA
12560.29282.2(15.7)--
In millions of CNY, except % and values per 1 share